Norethindrone Acetate and Ethinyl Estradiol Tablets and Ferrous Fumarate Tablets

FDA Drug Profile — Norethindrone Acetate and Ethinyl Estradiol

Drug Details

Generic Name
Norethindrone Acetate and Ethinyl Estradiol Tablets and Ferrous Fumarate Tablets
Brand Names
Norethindrone Acetate and Ethinyl Estradiol
Application Number
ANDA209609
Sponsor
Xiromed, LLC
NDC Codes
1
Dosage Forms
KIT
Routes
ORAL
Active Ingredients
N/A

Indications and Usage

1 INDICATIONS AND USAGE Norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets is indicated for use by females of reproductive age to prevent pregnancy [see Clinical Studies ( 14 )] The efficacy of norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets in women with a body mass index (BMI) of more than 35 kg/m 2 has not been evaluated. norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets is an estrogen/progestin COC indicated for use by women to prevent pregnancy ( 1 ) The efficacy in women with a body mass index of more than 35 kg/m 2 has not been evaluated ( 1 , 8.8 )